Diede van Lamoen
Managing Partner @ Go Global Ventures
San Francisco, United States
Diede van Lamoen is a Series A investor at Go Global Ventures in San Francisco focused on FinTech and Health Care. Diede van Lamoen serves as a Managing Partner at Go Global Ventures.
- Total investments:
- 9
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Diede van Lamoen invests in
Stages Diede van Lamoen invests in
Countries Diede van Lamoen invests in
Round sizes
Round size
- Seed
- $4.5M–$14M
- Series A
- $5.8M–$50M
Investment Focus
Industry
- FinTech 3 (33%)
- Health Care 3 (33%)
- SaaS 2 (22%)
- Accounting 2 (22%)
- Mobile Apps 2 (22%)
Stage
- Series A 6 (67%)
- Seed 2 (22%)
- Funding Round 1 (11%)
Country
- United States 6 (67%)
- Chile 1 (11%)
- United Kingdom 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Radial
|
Radial provides new medical treatments for mental conditions including treatments like neuromodulation and rapid acting medications. | $50M / Series A / Dec 09, 2025 | |
Nolla Health
|
Nolla Health is a technology-driven healthcare company that focuses on developing AI-powered digital doctors, starting with skin health and dermatology. | $4.5M / Seed / Sep 18, 2025 | |
Manifest
|
Manifest is a cybersecurity firm focused on assisting businesses in securing their software supply chains. Manifest is creating the first all-in-one SBOM management platform. | $15M / Series A / Apr 24, 2025 | |
Amulet
|
Amulet is shining a light on invisible threats in our food system. Amulet has two core brands: - Allergy Amulet helps consumers determine whether their foods are safe by detecting potentially life-threatening allergenic ingredients. - Amulet Scientific equips businesses and manufacturers with tools to help ensure the safety of their food supplychain. Learn more: www.allergyamulet.com www.amuletscientific.com | $5.8M / Series A / Aug 12, 2024 | |
Amulet
|
Allergy Amulet is the world’s smallest and fastest consumer food allergen sensor, testing for common allergenic ingredients in seconds. Whether it’s on a keychain, a necklace, a wristband, or in a pocket, Allergy Amulet’s sleek and portable design allows users to savor life’s important moments, safely and simply. Food allergies affect 32 millionAmericans and between 220-520 million people globally. That’s 1 in 13 children and 1 in 10 adults. Allergy Amulet has the potential to improve the quality of life for the millions of people living with food allergies or intolerances. | $5.8M / Series A / Aug 12, 2024 | |
Rillet
|
Rillet is an AI-native ERP that automates accounting for complex revenue models, allowing for fast book closings and providing a reliable source of truth. The solution covers the full spectrum of accounting and finance needs, including customer invoicing, GAAP-compliant revenue recognition, automated bank reconciliations, accrual-based expenserecognition, real-time SaaS metrics, and other analytics capabilities. Rillet covers multiple entities, geographies, and currencies and allows for consolidated multi-currency reportin,g all embedded within one platform. | $13.5M / Jul 29, 2024 | |
|
Rillet
|
Rillet is an AI-native ERP that automates accounting for complex revenue models, allowing for fast book closings and providing a reliable source of truth. The solution covers the full spectrum of accounting and finance needs, including customer invoicing, GAAP-compliant revenue recognition, automated bank reconciliations, accrual-based expenserecognition, real-time SaaS metrics, and other analytics capabilities. Rillet covers multiple entities, geographies, and currencies and allows for consolidated multi-currency reportin,g all embedded within one platform. | $13.5M / Seed / Jul 29, 2024 | |
Fintoc
|
Fintoc is an API that lets online businesses accept instant payments coming directly from the customer’s bank account. The company was founded in March 2020 by Cristóbal Griffero and Lukas Zorich and is headquartered in Santiago, Region Metropolitana, Chile. | $7M / Series A / Apr 25, 2024 | |
Pento
|
Pento makes payroll painless, empowering HR & Finance teams by streamlining automation, calculation, payments, compliance & reporting. Pento provides a SaaS-based online platform that optimizes payroll services, enabling companies of all sizes to process pay with ease - but without a lot of time! Pento automates salary processing, taxes andis fully connected to HMRC, as well as offering a range of HRIS & accounting/ERP integrations, to make managing compensation and benefits a breeze.Active in the UK since 2020, Pento is remote-first, with a nominal HQ in London, United Kingdom. | $15.5M / Series A / May 19, 2021 |
Co-Investors
About Go Global Ventures
Go Global Ventures is an investment firm.
Go Global Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Diede van Lamoen
Managing Partner
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Diede van Lamoen invest in?
Diede van Lamoen invests primarily in FinTech, Health Care and SaaS startups, most often at Series A and Seed stage. Most of the 9 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Diede van Lamoen's check size?
Diede van Lamoen typically joins rounds of $4.5M–$14M at Seed and $5.8M–$50M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Diede van Lamoen participates in.
When did Diede van Lamoen last invest?
The most recent investment recorded for Diede van Lamoen closed in Dec 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
